Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rudick Richard Alan Insider Profile
4 Followers
Rudick Richard Alan, Director at Immunic, holds 87.30K shares in Immunic (Ticker: IMUX). Most recently, Rudick Richard Alan Bought $87,300 shares of Immunic on Nov 13, 2024 for an estimated value of 99.52K.
Rudick Richard Alan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Rudick Richard Alan's holdings
Insider Roles
Director
Roles that Rudick Richard Alan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Rudick Richard Alan
Rudick Richard Alan's Trading History
List of latest transactions for each holding click on a transaction to see Rudick Richard Alan's performance on stock
You May Also Like
Rudick Richard Alan insider profile FAQ
What is the percentage of profitable transactions made by Rudick Richard Alan?
The percentage of profitable transactions made by Rudick Richard Alan is ―.
What is the average return per transaction made by Rudick Richard Alan?
The average return per transaction made by Rudick Richard Alan is ―.
What stocks does Rudick Richard Alan hold?
Rudick Richard Alan holds: IMUX stocks.
What was Rudick Richard Alan’s latest transaction?
Rudick Richard Alan latest transaction was an Informative Buy of $99.52K.
What was Rudick Richard Alan's most profitable transaction?
Rudick Richard Alan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Rudick Richard Alan's role in Immunic?
Rudick Richard Alan's role in Immunic is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.